Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Edetate calcium disodium is a chelating agent used to treat lead poisoning. It is on the World Health Organization Model List of Essential Medicines.
- Mechanism
- Curator reviewed · 5 references
Edetate calcium disodium distributes into tissues, such as the kidney and bone, where it chelates lead ions. The lead ions are then eliminated in the normal urinary excretion of edetate. Lead in certain tissues such as the liver and bone, redistribute to other tissues after edetate calcium disodium treatment, but lead levels do not decrease to levels seen in unexposed patients.
- Primary indication
- Edetate calcium disodium is indicated to reduce blood levels and depot stores of lead in acute and chronic lead poisoning.Curator reviewed · 1 structured indication
- Formula / weight
- C10H12CaN2Na2O8 · 374.268 g/mol (avg)
- First approval
- Canada, 1993 · United States, 2009
- Also known as
- Edetic acid calcium disodium salt
- Brand names
- Calcium Disodium Versenate
Resolves to
SHWNNYZBHZIQQV-UHFFFAOYSA-JSMILES[Na+].[Na+].[Ca++].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=OWhat you can answer from here — as of September 23, 2026
Which other approved drugs treat the same conditions as Edetate calcium disodium, and which companies have late-stage candidates in those indications?